Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germanyās BioNTech have started clinical trials for a vaccine to prevent both.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germanyās BioNTech have started clinical trials for a vaccine to prevent both.
HQ Team October 31, 2022: About 2.20 billion people across the board have been administered Covid-19 vaccines in India,Ā accordingĀ to the government. More than.
Scientists fear a resurgence of Covid-19 infections and deaths from antibody resistant BQ.1.1 strain
Pfizer set to increase Covid-19 vaccine prices by almost four times in the US
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.
Booster shots reduce severity of covid in cirrhosis patients
October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a āuniversalā method of treating Covid-19. According to.
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.
Scientists are hopeful of an mRNA based vaccine for cancer
The global response to combat the Covid-19 crisis lacked cooperation and coordination: WHO